Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction after Coronary Stenting, A Randomized Controlled Trial.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 17 May 2016
At a glance
- Drugs Ezetimibe (Primary) ; HMG-CoA reductase inhibitors
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms CuVIC
- 07 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 19 May 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 16 May 2011 New trial record